Stock Information
Opus Genetics Inc (IRD)
Ticker Symbol: IRD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $323.73 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.811
Revenue (TTM): $0.18 M
Dividend Yield: N/A%
ROE: -316.35%
Latest News
-
Opus Genetics Announces New Clinical And Preclinical Data From Multiple Programs Presented At Association For Research In Vision And Opthalmology Annual Meeting May 3-7
Thu, May 7, 2026 4:52 PM
-
Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal Diseases
Thu, May 7, 2026 4:30 PM
-
Opus Genetics Completes Enrollment in Cohort 1 of Phase 1/2 OPGx-BEST1 Gene Therapy Study
Thu, May 7, 2026 7:02 AM
-
Opus Genetics Gene Therapy Accepted into FDA's Rare Disease Program
Mon, May 4, 2026 5:58 PM
-
Opus Genetics' OPGx-LCA5 Program Accepted Into FDA's Rare Disease Evidence Principles Program
Mon, May 4, 2026 4:41 PM
-
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
Mon, May 4, 2026 4:31 PM
Key Financials
Financial data not available
